MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
21.00
+0.64
+3.14%
After Hours: 21.00 0 0.00% 17:43 02/06 EST
OPEN
20.61
PREV CLOSE
20.36
HIGH
21.07
LOW
20.44
VOLUME
746.55K
TURNOVER
--
52 WEEK HIGH
27.64
52 WEEK LOW
18.80
MARKET CAP
903.45M
P/E (TTM)
45.03
1D
5D
1M
3M
1Y
5Y
1D
Pacira BioSciences SVP Finance Lauren Riker Reports Disposal of Common Shares
Reuters · 4d ago
Pacira Biosciences Chief Administrative Officer Kristen Williams Reports Disposal of Common Shares
Reuters · 4d ago
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
NASDAQ · 4d ago
Weekly Report: what happened at PCRX last week (0126-0130)?
Weekly Report · 6d ago
Pacira Biosciences Files Initial Beneficial Ownership Statement for Director Samit Hirawat
Reuters · 01/29 21:50
Pacira BioSciences adds seasoned leader to board
TipRanks · 01/28 13:39
Pacira appoints Samit Hirawat to board of directors
TipRanks · 01/28 13:15
Pacira Biosciences Appoints Samit Hirawat to Board of Directors
Reuters · 01/28 13:00
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.